Health & Fitness

WHO discontinues hydroxychloroquine, lopinavir/ritonavir trial for Covid-19 treatment

WHO team to reach China next week to probe SARS-CoV-2 source

Scientists find new way to better diagnose malaria infection in India

EU authorises remdesivir for Covid-19 treatment

Zydus vaccine gets DCGI nod for human trial

WHO: Covid-19 hitting livelihoods, causing anxiety, stress

Fauci warns of 100,000 COVID cases per day in US

Living with COVID-19 to be new normal as global cases top 10 mln: WHO

Global COVID-19 cases top 9.7mn: Johns Hopkins University

WHO says AstraZeneca, Modena leading vaccine race

Covid-19 drug priced Rs 5,400 per vial by Hyderabad-based Hetero

Cipla's Covid-19 drug Cipremi set to cost less than Rs 5K per vial

Over 9.2 mn Covid cases reported worldwide

Ramdev's Corona cure: All you need to know about Coronil

Boost your immunity to sail through the Monsoon

First open source all-atom models of Covid-19 protein developed


San Francisco,  A team of scientists has produced first open source all-atom models of full-length COVID-19 Spike protein that facilitates viral entry into host cells – a discovery that can facilitate a faster vaccine and antiviral drug development.

Pandemic entering 'new and dangerous phase': WHO



Geneva,  The World Health Organization has warned that the Covid-19 pandemic is entering a "new and dangerous" phase. Thursday saw the most cases in a single day reported to the WHO.

Tedros Adhanom Ghebreyesus said the day had seen 150,000 new cases with half of those coming from the Americas and large numbers also from the Middle East and South Asia, the BBC reported.

This vaccine may protect against worst symptoms of Covid-19

New York,  The MMR (measles, mumps, rubella) vaccine could serve as a preventive measure to dampen septic inflammation associated with Covid-19 infection, say researchers.

According to the study, published in the journal mBio, vaccination with MMR in immunocompetent individuals has no contraindications and may be especially effective for health care workers who can easily be exposed to Covid-19.

WHO hopes 2 billion Covid-19 vaccine doses by next year

London,  Dr Soumya Swaminathan, who is the chief scientist at the World Health Organisation (WHO) on Thursday, said that nearly 2 billion doses of the Covid-19 vaccine would be ready by the end of next year.

WHO concerned over COVID-19 upswing in many countries



Geneva, World Health Organization (WHO) said that it's concerned that many countries, particularly the global south, are still on the upswing of the COVID-19 pandemic, and again called for global solidarity to overcome difficulties for "over 100 years."

Israeli varsity says new findings may lead to COVID vaccine



Jerusalem, Israeli researchers have identified coronavirus molecules that may lead to the development of a vaccine against the virus, Bar Ilan University (BIU) in central Israel said.

In a study published in the journal MDPI Vaccines on Thursday, BIU researchers examined antigen molecules, that provoke an immune response of antibody production, Xinhua news agency reported.

US to conduct key studies on three possible COVID-19 vaccines: Fauci


Washington,  The US government will fund and conduct key studies on three experimental coronavirus vaccines, said the nation's top infectious disease expert Anthony Fauci.

"The coronavirus vaccine effort is progressing very well and we expect more than one candidate vaccine to be in advanced clinical testing by early summer," Fauci, director of the US National Institute of Allergy and Infectious Diseases, told CNN on Wednesday.

Drinking fruit juice can have long term dietary benefits: Study


New York,  Drinking 100 per cent fruit juice early in life was associated with healthier dietary patterns in later childhood without adversely impacting weight gain, say researchers.

The study, published in the BMC Nutrition, found that consumption of 100 per cent fruit juice was associated with higher intakes of whole fruit and total fruit as well as better diet quality through childhood and into middle adolescence.

US researchers identify targets for Covid-19 vaccine

New York,  Researchers in the US have identified regions of the novel coronavirus (SARS-CoV-2) to target with a vaccine, by harnessing tools used for the development of cancer immunotherapies.

Using this strategy, the researchers believe a resulting vaccine would provide protection across the human population and drive a long-term immune response, the study, published in the journal Cell Reports Medicine, said.

In many ways, cancer behaves like a virus, so the research team decided to use the tools they developed to identify unique aspects of childhood cancers that can be targeted with immunotherapies and apply those same tools to identify the right protein sequences to target in SARS-CoV-2

'Historic commitments' at Global Vaccine Summit



London,  The virtual Global Vaccine Summit hosted by the UK drew pledges of $8.8 billion, far more than its target of $7.4 billion, showing "historic commitments" made by world leaders to provide equal access to vaccines for all.

On Thursday, UK Prime Minister Boris Johnson opened the Global Vaccine Summit virtually, urging countries and organizations to pledge funding for vaccinations to save millions of lives in the poorest countries and protect the world from future outbreaks of infectious diseases, reports Xinhua news agency.

The best idea always remains in the imagination: Nisha Mathew Ghosh


New Delhi, Believing that a crisis is an opportunity to start again, by thinking anew, she feels that there will be a shift in the spatial typology of our institutions in an age of a new awareness of viruses and human safety. Considering it to be the perfect time to have a long radical view at our accountability and stewardship of the ecology of our specific landscapes, Nisha Mathew Ghosh, curator of India Pavilion at the London Design Biennale scheduled to take place in September, but currently postponed to June 2021 owing to the Covid crisis adds, "It is a fundamental right as a human being to breathe clean air, use clear fresh water and grow vegetables on clean earth."

WHO includes hydroxychloroquine in solidarity trial again


New Delhi, The World Health Organisation on Wednesday said that anti-malarial drug hydroxychloroquine (HCQ) will return to the solidarity trial for the potential treatment of coronavirus disease.

At a press conference in the WHO headquarters in Geneva, Director General Tedros Adhanom Ghebreyesus said: "On the basis of the available mortality data, the members of the committee recommended that there are no reasons to modify the trial protocol.

WHO warns of disturbing rates of antimicrobial resistance during COVID-19 pandemic

Geneva, The World Health Organisation (WHO) Director-General Tedros Adhanom Ghebreyesus warned that the world is "losing its ability" to use critically important antimicrobial medicines.

Speaking at a virtual press conference on Monday, the WHO chief said that the COVID-19 pandemic has led to an increased use of antibiotics, which ultimately will lead to higher bacterial resistance rates, Xinhua news agency reported.

Global COVID-19 cases nearly 6 mn: Johns Hopkins



Washington,  The total number of global coronavirus cases was nearing the 6 million mark, while the deaths have surged to more than 364,000, according to the Johns Hopkins University.

As of Saturday morning, the overall number of cases stood at 5,923,432, while the death toll increased to 364,849, the University's Center for Systems Science and Engineering (CSSE) revealed in its latest update.

Healthcare facilities in India see 80% fall in revenue: Survey

New Delhi,  The Covid-19 pandemic has left the Indian private healthcare sector in acute financial distress, a new survey said on Friday adding that the healthcare facilities in the country have witnessed at least 80 per cent fall in average revenue.

Post the lockdown from March 24, Indian hospitals have seen a large impact, especially among small and medium-sized hospitals, which are now facing existential challenges.

Music, yoga and menu of choice, this quarantine centre is different

Jaipur,  A COVID-care centre in Dungarpur district of Rajasthan has emerged as a role model by setting up new benchmarks as it offers music, meditation, aerobics along with the choicest of menu for the people staying here!

Called as Parda Chundawat Quarantine Centre, it has set example by creating a serene environment where people wake up listening to soothing music. Then, there are Yoga and meditation classes where they exercise to shoo off negativity from their mind.

Lipstick effect, revenge buying to drive Indian consumers post Covid

New Delhi,  For the coming few months, Indian consumers may forego big ticket retail purchases, but may go for reasonably priced indulgences, or what is called a Lipstick Effect.

According to a research by RedQuanta on what Indian consumers are thinking, brands selling reasonably priced feel-good indulgences or accessories will benefit.

Among the cultural trends likely to impact retail businesses is the Lipstick Effect. "Faced with a short-term cash deficit, consumers may forgo big-ticket retail items like a luxury bag in favour of a small but still premium product like a good quality lipstick," the research said.

COVID-19 vaccines must be recognised as public goods: WHO


Geneva,  The World Health Organization (WHO) has reiterated that COVID-19 vaccines must be recognised as public goods for the whole world, and that all countries must contribute.

"We can't prevent pathogens, germs from crossing our borders. And that's why these vaccines have to be recognised as protecting the whole of the world and the contributions from every country to do that," Katherine O'Brien, director of WHO's Department of Immunization, Vaccines and Biologicals, said in a press conference in Geneva on Friday, reiterating COVID-19 vaccines be recognized as "global public health goods", Xinhua reported.

Global COVID-19 cases top 5.1 mn: Johns Hopkins


Washington, The overall number of global coronavirus cases has surged to over 5.1 million, while the death toll stood at 332,900, according to the Johns Hopkins University.

As of Friday morning, the total number of cases stood at 5,101,967, the University's Center for Systems Science and Engineering (CSSE) revealed in its latest update.

Over 100,000 new Covid cases recorded in last 24 hrs: WHO

Geneva,  Highlighting its continuing peril around the world even as its spread slows in some areas of Asia and Europe and lockdown restrictions are eased, coronavirus has infected 106,000 people in the last 24 hours - the largest number of cases since its outbreak, the WHO said on Wednesday.

Patients with coronavirus infections may experience mental problems

 

London, People taken ill by coronavirus infections may experience psychiatric problems while hospitalised and potentially after they recover, warn researchers.

The systematic review, published in the journal 'The Lancet Psychiatry', compiled results from short- and long-term studies of people hospitalised by recent coronaviruses, namely SARS (Severe acute respiratory syndrome) in 2002-2004, MERS (Middle East respiratory syndrome) in 2012, as well as COVID-19 this year.

India among 58 nations questioning WHO on COVID-19 response


New Delhi, India is among 58 nations, including 27 European Union members, who have moved a draft resolution demanding evaluation of the World Health Organisation (WHO)'s response towards the novel coronavirus pandemic.

The European Union-led draft resolution on global COVID-19 response is set to be tabled at the upcoming World Health Assembly on Monday.

Combination of zinc, HCQ & azithromycin helps in recovery from COVID-19: Shanghai-based Indian Doc


New Delhi, China, where the novel coronavirus originated, has reported 111 cases since beginning of May, which shows the infection rate has dipped, and 3 deaths since April 27, according to the WHO. A Shanghai-based Noida doctor says China is close to winning the battle against Covid-19, and the combination of zinc, hydroxychloroquine (HCQ) and antibiotic azithromycin has been able to save the lives of coronavirus patients. Speaking to IANS, Dr Sanjeev Choubey, Medical Director Internal Medicine at St. Michael Hospital said this combination has been adopted as a line of treatment for patients infected with coronavirus, and as a result patients are recovering, decreasing their need for intensive care.

Global COVID-19 cases reach over 4.5mn: Johns Hopkins


Washington, The overall number of global coronavirus cases has increased to over 4.5 million, while the death toll has surpassed 307,000, according to the Johns Hopkins University.

As of Saturday morning, the total number of cases stood at 4,538,406, while the death toll increased to 307,486, the University's Center for Systems Science and Engineering (CSSE) revealed in its latest update.

No approved treatments yet for COVID-19: WHO

 

Geneva, The World Health Organization (WHO) said that a number of treatments are under clinical trials for the treatment of COVID-19, but none of those were yet approved.

"There are hundreds of clinical trials that are underway, and the reason we need to wait for the results of these studies is because they are evaluating how these medicines, how these drugs work, in terms of either preventing infection, preventing someone from progressing to severe disease, preventing death and how safe they are, do they have any side effects," Maria Van Kerkhove, technical lead for the WHO's Health Emergencies Program, said on Friday in a press conference in Geneva, Xinhua news agency reported.

12345678910...